Authors:
Koulinska, IN
Ndung'u, T
Mwakagile, D
Msamanga, G
Kagoma, C
Fawzi, W
Essex, M
Renjifo, B
Citation: In. Koulinska et al., A new human immunodeficiency virus type 1 circulating recombinant form from Tanzania, AIDS RES H, 17(5), 2001, pp. 423-431
Authors:
Messele, T
De Wit, TFR
Brouwer, M
Aklilu, M
Birru, T
Fontanet, AL
Schuitemaker, H
Hamann, D
Citation: T. Messele et al., No difference in in vitro susceptibility to HIV type 1 between high-risk HIV-negative ethiopian commercial sex workers and low-risk control subjects, AIDS RES H, 17(5), 2001, pp. 433-441
Authors:
Miller, LS
Atabai, K
Nowakowski, M
Chan, A
Bluth, MH
Minkoff, H
Durkin, HG
Citation: Ls. Miller et al., Increased expression of CD23 (Fc epsilon receptor II) by peripheral blood monocytes of AIDS patients, AIDS RES H, 17(5), 2001, pp. 443-452
Authors:
Parekh, BS
Hu, DJ
Vanichseni, S
Satten, GA
Candal, D
Young, NL
Kitayaporn, D
Srisuwanvilai, LO
Rakhtam, S
Janssen, R
Choopanya, K
Mastro, TD
Citation: Bs. Parekh et al., Evaluation of a sensitive/less-sensitive testing algorithm using the 3A11-LS assay for detecting recent HIV seroconversion, among individuals with HIV-1 subtype B or E infection in Thailand, AIDS RES H, 17(5), 2001, pp. 453-458
Authors:
Fortgang, IS
Rege, T
Baskin, GB
Murphey-Corb, M
Levy, LS
Citation: Is. Fortgang et al., Variation in simian immunodeficiency virus env V1 region in simian AIDS-Associated lymphoma, AIDS RES H, 17(5), 2001, pp. 459-465
Authors:
Hejdeman, B
Lenkei, R
Leandersson, AC
Hultstrom, AL
Wahren, B
Sandstrom, E
Bratt, G
Citation: B. Hejdeman et al., Clinical and immunological benefits from highly active antiretroviral therapy in spite of limited viral load reduction in HIV type 1 infection, AIDS RES H, 17(4), 2001, pp. 277-286
Authors:
Espersen, C
Pakkenberg, B
Harder, E
Pallesen, G
Gerstoft, J
Pedersen, BK
Ullum, H
Citation: C. Espersen et al., High levels of CD8-positive lymphocytes expressing CD45R0, granzyme B, andKappa i-67 in lymph nodes of HIV-infected individuals are not associated with increased mortality, AIDS RES H, 17(4), 2001, pp. 287-293
Citation: K. Dern et al., Inhibition of HIV type 1 replication by simultaneous infection of peripheral blood lymphocytes with human immunodeficiency virus types 1 and 2, AIDS RES H, 17(4), 2001, pp. 295-309
Authors:
Daniel, V
Susal, C
Weimer, R
Zimmermann, R
Huth-Kuhne, A
Opelz, G
Citation: V. Daniel et al., Increased soluble Fas in HIV-infected hemophilia patients with CD4(+) and CD8(+) cell count increases and viral load and immune complex decreases, AIDS RES H, 17(4), 2001, pp. 329-335
Authors:
Tallet, B
Astier-Gin, T
Moynet, D
Londos-Gagliardi, D
Guillemain, B
Citation: B. Tallet et al., Sequence variations in the amino- and carboxy-terminal parts of the surface envelope glycoprotein of HTLV type 1 induce specific neutralizing antibodies, AIDS RES H, 17(4), 2001, pp. 337-348
Authors:
Huete, JMB
Chatis, PA
Schmitz, JE
Kuroda, MJ
Letvin, NL
Reimann, KA
Citation: Jmb. Huete et al., Detection of viral RNA in CD4(-) CD8(-) and CD4(-) CD8(-) lymphocytes in vivo in rhesus monkeys infected with simian immunodeficiency virus of macaques, AIDS RES H, 17(4), 2001, pp. 349-360
Authors:
Yang, CF
Dash, B
Hanna, SL
Frances, HS
Nzilambi, N
Colebunders, RC
St Louis, M
Quinn, TC
Folks, TM
Lal, RB
Citation: Cf. Yang et al., Predominance of HIV type 1 subtype G among commercial sex workers from Kinshasa, Democratic Republic of Congo, AIDS RES H, 17(4), 2001, pp. 361-365
Authors:
Choi, JY
Kim, JS
Lee, JM
Hyun, BH
Kim, HS
Citation: Jy. Choi et al., Isolation and phylogeny of new endogenous retroviral sequences belonging to the HERV-F family, AIDS RES H, 17(4), 2001, pp. 367-370
Authors:
Wade-Evans, AM
Russell, J
Jenkins, A
Javan, C
Citation: Am. Wade-evans et al., Cloning and sequencing of cynomolgus macaque CCR3, GPR15, and STRL33: Potential coreceptors for HIV type 1, HIV type 2, and SIV, AIDS RES H, 17(4), 2001, pp. 371-375
Authors:
Katzenstein, DA
Hughes, MD
Albrecht, M
Liou, SH
Murphy, R
Balfour, H
Para, M
Hammer, S
Citation: Da. Katzenstein et al., Virologic and CD4 cell response to zidovudine or zidovudine and lamivudinefollowing didanosine treatment of human immunodeficiency virus infection, AIDS RES H, 17(3), 2001, pp. 203-210
Authors:
Dronda, F
Casado, JL
Moreno, S
Hertogs, K
Garcia-Arata, I
Antela, A
Perez-Elias, MJ
Ruiz, L
Larder, B
Citation: F. Dronda et al., Phenotypic cross-resistance to nelfinavir: The role of prior antiretroviral therapy and the number of mutations in the protease gene, AIDS RES H, 17(3), 2001, pp. 211-215
Authors:
De Souza, MS
Trichavaroj, R
Sriplienchan, S
Buapunth, P
Renzullo, PO
Chuenchitra, C
Birx, DL
Robb, ML
Brown, AE
Citation: Ms. De Souza et al., Detection and quantification of HIV type 1 RNA in nasopharyngeal washes from HIV-infected subjects, AIDS RES H, 17(3), 2001, pp. 229-232
Authors:
Young, JM
Ffrench, RA
Clarkson, JD
Stewart, GJ
Liang, T
Tideman, RL
Packham, D
Fulcher, DA
Benson, EM
Citation: Jm. Young et al., In vitro HIV-specific CTL activity from HIV-seropositive individuals is augmented by interleukin-12 (IL-12), AIDS RES H, 17(3), 2001, pp. 233-242
Authors:
Leutenegger, CM
Higgins, J
Matthews, TB
Tarantal, AF
Luciw, PA
Pedersen, NC
North, TW
Citation: Cm. Leutenegger et al., Real-time TaqMan PCR as a specific and more sensitive alternative to the branched-chain DNA assay for quantitation of simian immunodeficiency virus RNA, AIDS RES H, 17(3), 2001, pp. 243-251
Authors:
Esteves, A
Piedade, J
Santos, C
Venenno, T
Canas-Ferreira, WF
Parreira, R
Citation: A. Esteves et al., Follow-up study of intrahost HIV type 2 variability reveals discontinuous evolution of C2V3 sequences, AIDS RES H, 17(3), 2001, pp. 253-256
Authors:
Bobkov, A
Kazennova, E
Khanina, T
Bobkova, M
Selimova, L
Kravchenko, A
Pokrovsky, V
Weber, J
Citation: A. Bobkov et al., An HIV type 1 subtype a strain of low genetic diversity continues to spread among injecting drug users in Russia: study of the new local outbreaks inMoscow and Irkutsk, AIDS RES H, 17(3), 2001, pp. 257-261